Safety and efficacy of TRIplet combination of nivolumab (N) with dabrafenib (D) and trametinib (T) [TRIDeNT] in patients (pts) with BRAF-mutated metastatic melanoma (MM): A single center phase II study
Gespeichert in:
| Veröffentlicht in: | Annals of oncology 2019-10, Vol.30, p.v534-v535 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | v535 |
|---|---|
| container_issue | |
| container_start_page | v534 |
| container_title | Annals of oncology |
| container_volume | 30 |
| creator | Burton, E.M. Amaria, R.N. Glitza, I.C. Shephard, M. Diab, A. Milton, D. Patel, S. Mcquade, J. Wong, M. Hwu, P. Wargo, J. Davies, M.A. Tawbi, H.A. |
| description | |
| doi_str_mv | 10.1093/annonc/mdz255.002 |
| format | Article |
| fullrecord | <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1093_annonc_mdz255_002</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1093_annonc_mdz255_002</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1332-2af5ff94e577fc0cf7c2d8674d3302fec8cfc433bb99edc77bb26ad86d1de1c3</originalsourceid><addsrcrecordid>eNotkM1OwkAUhbvQREQfwN1dwqIwnaGUukMQJQFMsDtjmtv5kTHttOkMGnxD38oBXN2Tk3O_xRcEdxEZRCRlQzSmNnxYiR8axwNC6EXQISllYRKz0VVwbe0nIWSc0rQT_L6iku4AaARIpTRHfoBaQbZdNqV0wOuq0Aadrs2xNvqrLvcVFtDb9OFbux0ILFrPMNp38_4J5FqspNOnKuvDm4fN5SZ7B22g8SxpnIVe4-w_4mE7XYTV3qGTAvwnWh8197FEU1cIvfW6fw9TsNp8lBK4B8gWmh1aCcslWLcXh5vgUmFp5e3_7QbZ4jGbPYerl6flbLoKecQYDSmqWKl0JOMkUZxwlXAqJuNkJBgjVEk-4YqPGCuKNJWCJ0lR0DH6hYiEjDjrBtEZy9va2laqvGl1he0hj0h-1J-f9edn_bnXz_4Ao9V_gQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Safety and efficacy of TRIplet combination of nivolumab (N) with dabrafenib (D) and trametinib (T) [TRIDeNT] in patients (pts) with BRAF-mutated metastatic melanoma (MM): A single center phase II study</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Burton, E.M. ; Amaria, R.N. ; Glitza, I.C. ; Shephard, M. ; Diab, A. ; Milton, D. ; Patel, S. ; Mcquade, J. ; Wong, M. ; Hwu, P. ; Wargo, J. ; Davies, M.A. ; Tawbi, H.A.</creator><creatorcontrib>Burton, E.M. ; Amaria, R.N. ; Glitza, I.C. ; Shephard, M. ; Diab, A. ; Milton, D. ; Patel, S. ; Mcquade, J. ; Wong, M. ; Hwu, P. ; Wargo, J. ; Davies, M.A. ; Tawbi, H.A.</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>DOI: 10.1093/annonc/mdz255.002</identifier><language>eng</language><ispartof>Annals of oncology, 2019-10, Vol.30, p.v534-v535</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1332-2af5ff94e577fc0cf7c2d8674d3302fec8cfc433bb99edc77bb26ad86d1de1c3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Burton, E.M.</creatorcontrib><creatorcontrib>Amaria, R.N.</creatorcontrib><creatorcontrib>Glitza, I.C.</creatorcontrib><creatorcontrib>Shephard, M.</creatorcontrib><creatorcontrib>Diab, A.</creatorcontrib><creatorcontrib>Milton, D.</creatorcontrib><creatorcontrib>Patel, S.</creatorcontrib><creatorcontrib>Mcquade, J.</creatorcontrib><creatorcontrib>Wong, M.</creatorcontrib><creatorcontrib>Hwu, P.</creatorcontrib><creatorcontrib>Wargo, J.</creatorcontrib><creatorcontrib>Davies, M.A.</creatorcontrib><creatorcontrib>Tawbi, H.A.</creatorcontrib><title>Safety and efficacy of TRIplet combination of nivolumab (N) with dabrafenib (D) and trametinib (T) [TRIDeNT] in patients (pts) with BRAF-mutated metastatic melanoma (MM): A single center phase II study</title><title>Annals of oncology</title><issn>0923-7534</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNotkM1OwkAUhbvQREQfwN1dwqIwnaGUukMQJQFMsDtjmtv5kTHttOkMGnxD38oBXN2Tk3O_xRcEdxEZRCRlQzSmNnxYiR8axwNC6EXQISllYRKz0VVwbe0nIWSc0rQT_L6iku4AaARIpTRHfoBaQbZdNqV0wOuq0Aadrs2xNvqrLvcVFtDb9OFbux0ILFrPMNp38_4J5FqspNOnKuvDm4fN5SZ7B22g8SxpnIVe4-w_4mE7XYTV3qGTAvwnWh8197FEU1cIvfW6fw9TsNp8lBK4B8gWmh1aCcslWLcXh5vgUmFp5e3_7QbZ4jGbPYerl6flbLoKecQYDSmqWKl0JOMkUZxwlXAqJuNkJBgjVEk-4YqPGCuKNJWCJ0lR0DH6hYiEjDjrBtEZy9va2laqvGl1he0hj0h-1J-f9edn_bnXz_4Ao9V_gQ</recordid><startdate>201910</startdate><enddate>201910</enddate><creator>Burton, E.M.</creator><creator>Amaria, R.N.</creator><creator>Glitza, I.C.</creator><creator>Shephard, M.</creator><creator>Diab, A.</creator><creator>Milton, D.</creator><creator>Patel, S.</creator><creator>Mcquade, J.</creator><creator>Wong, M.</creator><creator>Hwu, P.</creator><creator>Wargo, J.</creator><creator>Davies, M.A.</creator><creator>Tawbi, H.A.</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201910</creationdate><title>Safety and efficacy of TRIplet combination of nivolumab (N) with dabrafenib (D) and trametinib (T) [TRIDeNT] in patients (pts) with BRAF-mutated metastatic melanoma (MM): A single center phase II study</title><author>Burton, E.M. ; Amaria, R.N. ; Glitza, I.C. ; Shephard, M. ; Diab, A. ; Milton, D. ; Patel, S. ; Mcquade, J. ; Wong, M. ; Hwu, P. ; Wargo, J. ; Davies, M.A. ; Tawbi, H.A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1332-2af5ff94e577fc0cf7c2d8674d3302fec8cfc433bb99edc77bb26ad86d1de1c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Burton, E.M.</creatorcontrib><creatorcontrib>Amaria, R.N.</creatorcontrib><creatorcontrib>Glitza, I.C.</creatorcontrib><creatorcontrib>Shephard, M.</creatorcontrib><creatorcontrib>Diab, A.</creatorcontrib><creatorcontrib>Milton, D.</creatorcontrib><creatorcontrib>Patel, S.</creatorcontrib><creatorcontrib>Mcquade, J.</creatorcontrib><creatorcontrib>Wong, M.</creatorcontrib><creatorcontrib>Hwu, P.</creatorcontrib><creatorcontrib>Wargo, J.</creatorcontrib><creatorcontrib>Davies, M.A.</creatorcontrib><creatorcontrib>Tawbi, H.A.</creatorcontrib><collection>CrossRef</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Burton, E.M.</au><au>Amaria, R.N.</au><au>Glitza, I.C.</au><au>Shephard, M.</au><au>Diab, A.</au><au>Milton, D.</au><au>Patel, S.</au><au>Mcquade, J.</au><au>Wong, M.</au><au>Hwu, P.</au><au>Wargo, J.</au><au>Davies, M.A.</au><au>Tawbi, H.A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Safety and efficacy of TRIplet combination of nivolumab (N) with dabrafenib (D) and trametinib (T) [TRIDeNT] in patients (pts) with BRAF-mutated metastatic melanoma (MM): A single center phase II study</atitle><jtitle>Annals of oncology</jtitle><date>2019-10</date><risdate>2019</risdate><volume>30</volume><spage>v534</spage><epage>v535</epage><pages>v534-v535</pages><issn>0923-7534</issn><doi>10.1093/annonc/mdz255.002</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0923-7534 |
| ispartof | Annals of oncology, 2019-10, Vol.30, p.v534-v535 |
| issn | 0923-7534 |
| language | eng |
| recordid | cdi_crossref_primary_10_1093_annonc_mdz255_002 |
| source | Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
| title | Safety and efficacy of TRIplet combination of nivolumab (N) with dabrafenib (D) and trametinib (T) [TRIDeNT] in patients (pts) with BRAF-mutated metastatic melanoma (MM): A single center phase II study |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T00%3A26%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Safety%20and%20efficacy%20of%20TRIplet%20combination%20of%20nivolumab%20(N)%20with%20dabrafenib%20(D)%20and%20trametinib%20(T)%20%5BTRIDeNT%5D%20in%20patients%20(pts)%20with%20BRAF-mutated%20metastatic%20melanoma%20(MM):%20A%20single%20center%20phase%20II%20study&rft.jtitle=Annals%20of%20oncology&rft.au=Burton,%20E.M.&rft.date=2019-10&rft.volume=30&rft.spage=v534&rft.epage=v535&rft.pages=v534-v535&rft.issn=0923-7534&rft_id=info:doi/10.1093/annonc/mdz255.002&rft_dat=%3Ccrossref%3E10_1093_annonc_mdz255_002%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |